DOI: 10.1016/s1367-5931(02)00350-2. Anti-integrin as novel drug-discovery targets: potential therapeutic and diagnostic implications

Anti-integrin as novel drug-discovery targets: potential therapeutic and diagnostic implications

10.1016/s1367-5931(02)00350-2

Crossref journal-article

Elsevier BV

Current Opinion in Chemical Biology (78)

Bibliography

Mousa, S. A. (2002). Anti-integrin as novel drug-discovery targets: potential therapeutic and diagnostic implications. Current Opinion in Chemical Biology, 6(4), 534â541.

Authors 1

Shaker A Mousa (first)

References 62 Referenced 49

10.1016/0092-8674(86)90259-X / Cell / Arg-Gly-Asp: a versatile cell recognition sequence by Ruoslahti (1986)
10.1016/0092-8674(92)90115-S / Cell / Integrins: versatility, modulation and signaling in cell adhesion by Hynes (1992)
10.1002/med.2610140203 / Med Res Rev / The pharmacology of the integrins by Cox (1994)
10.1096/fasebj.4.11.2199285 / FASEB J / Integrins and other cell adhesion molecules by Albelda (1990)
10.1016/S1569-2558(08)60204-0 / Adv Mol Cell Biol / Integrins: structure, function and biological properties by Cheresh (1993)
10.1126/science.8248807 / Science / A link between cyclin A expression and adhesion dependent cell cycle proliferation by Guadagno (1993)
10.1083/jcb.120.3.577 / J Cell Biol / Signal transduction from the extracellular matrix by Juliano (1993)
10.1073/pnas.88.19.8392 / Proc Natl Acad Sci USA / Signal transduction by integrins: increased protein tyrosine phosphorylation caused by clustering of β1 integrins by Kornberg (1991)
{'key': '10.1016/S1367-5931(02)00350-2_BIB9', 'first-page': '1101', 'article-title': 'Cell adhesion or integrin clustering increased phosphorylation of a focal adhesion associated kinase', 'volume': '117', 'author': 'Kornberg', 'year': '1992', 'journal-title': 'J Biol Chem'} / J Biol Chem / Cell adhesion or integrin clustering increased phosphorylation of a focal adhesion associated kinase by Kornberg (1992)
10.1038/358690a0 / Nature / Regulation of focal adhesion-associated protein tyrosine kinase by both cellular adhesion and oncogenic transformation by Guan (1992)
10.1091/mbc.3.9.989 / Mol Biol Cell / Signal transduction by the platelet integrin αIIbβ3: induction of calcium oscillations required for protein–tyrosine phosphorylation and ligand-induced spreading of stably transfected cells by Pelletier (1992)
10.1016/S0140-6736(94)90007-8 / Lancet / Randomized trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months by Topol (1994)
10.1016/S0140-6736(02)07442-1 / Lancet / Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials by Boersma (2002)
10.1016/S1359-6446(99)01394-X / Drug Discov Today / Antiplatelet therapies: from aspirin to GPIIb/IIIa receptor antagonists and beyond by Mousa (1999)
10.1124/jpet.301.2.747 / J Pharmacol Exp Ther / Pulmonary eosinophilia in a murine model of allergic inflammation is attenuated by small molecule alpha4beta1 antagonists by Kudlacz (2002)
10.1016/0092-8674(93)90305-A / Cell / α4β7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1 by Berlin (1994)
10.1016/0092-8674(90)90661-W / Cell / VCAM-1 on activated endothelium interacts with leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site by Elices (1990)
10.1016/S1367-5931(98)80120-8 / Curr Opin Chem Biol / Very late antigen 4 (VLA4) antagonists as anti-inflammatory agents by Lin (1998)
10.1001/archneur.59.3.391 / Arch Neurol / Migration of multiple sclerosis lymphocytes through brain endothelium by Prat (2002)
10.1002/ana.410370404 / Ann Neurol / The adhesion molecule and cytokine profile of multiple sclerosis lesions by Cannella (1995)
10.1016/0092-8674(94)90337-9 / Cell / Traffic signals for lymphocyte re-circulation and leukocyte emigration. The multistep paradigm by Springer (1994)
10.1161/01.ATV.18.9.1363 / Arterioscler Thromb Vasc Biol / Fibronectin: structure, assembly, and cardiovascular implications by Magnusson (1998)
10.1111/1523-1747.ep12500076 / J Invest Dermatol / Blood vessel fibronectin increases in conjunction with endothelial cell proliferation and capillary ingrowth during wound healing by Clark (1982)
10.1038/nbt1197-1271 / Nat Biotechnol / Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform by Neri (1997)
10.1242/dev.119.4.1079 / Development / Defects in mesodermal migration and vascular development in fibronectin-deficient mice by George (1993)
10.1016/0092-8674(92)90115-S / Cell / Integrins: versatility, modulation and signaling in cell adhesion by Hynes (1992)
Varner J, Mousa S: Antagonists of vascular cell integrin α5β1 inhibit angiogenesis. Circulation 1998, 98(Suppl):1, I-795, 4166.
Mousa S, Mohamed S, Smallhear J, Jadhav PK, Varner J: Anti-angiogenesis efficacy of small molecule a5b1 integrin antagonist, SJ749. Blood 1999, 94(Suppl I):620a, 2755.
10.1073/pnas.050587897 / Proc Natl Acad Sci USA / A non-peptide integrin antagonist can inhibit epithelial cell ingestion of streptococcus by blocking a5b1-fibronectin-M1 protein complex by Cleary (2000)
10.1016/S0002-8703(98)70239-X / Am Heart J / Long-term administration of glycoprotein IIb/IIIa antagonists by Quinn (1998)
10.1161/01.CIR.97.4.340 / Circulation / Randomized trial of an oral platelet glycoprotein IIb/IIIa antagonist, sibrafiban, in patients after an acute coronary syndrome: results of the TIMI 12 trial. Thrombolysis in myocardial infarction by Cannon (1998)
10.1161/01.CIR.98.13.1268 / Circulation / Pharmacodynamic efficacy, clinical safety, and outcomes after prolonged platelet glycoprotein IIb/IIIa receptor blockade with oral xemilofiban: results of a multicenter, placebo-controlled, randomized trial by Kereiakes (1998)
{'key': '10.1016/S1367-5931(02)00350-2_BIB33', 'first-page': '393A', 'article-title': 'Thrombocytopenia, bleeding, and thrombotic events with oral glycoprotein IIb/IIIa inhibition: results from OPUS-TIMI 16', 'volume': '35', 'author': 'Coulter', 'year': '2000', 'journal-title': 'J Am Coll Cardiol Suppl'} / J Am Coll Cardiol Suppl / Thrombocytopenia, bleeding, and thrombotic events with oral glycoprotein IIb/IIIa inhibition: results from OPUS-TIMI 16 by Coulter (2000)
The SYMPHONY Investigators: Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomized trial. Lancet 2000, 355:337-345. First published report of a large Phase III trial with an oral IIb/IIIa inhibitor. (10.1016/S0140-6736(99)11179-6)
10.1097/00003246-200205001-00025 / Crit Care Med / Platelet glycoprotein Iib/IIIa antagonists: lessons learned from clinical trials and future directions by Leclerc (2002)
10.1097/00019501-199809020-00011 / Coron Artery Dis / Novel technetium 99m-labeled GPIIb/IIIa receptor antagonists as potential imaging agents for venous and arterial thrombosis by Mousa (1998)
10.1016/S0008-6363(97)00184-3 / Cardiovasc Res / Selective αvβ3 integrin blockade limits neointima hyperplasia and lumen stenosis in stented porcine coronary artery injury in pig by Srivatsa (1997)
{'key': '10.1016/S1367-5931(02)00350-2_BIB38', 'first-page': '1505', 'article-title': 'A neutralizing antibody to the alpha v beta 3 integrin reduces neointimal thickening in a balloon-injured iliac artery', 'volume': '94', 'author': 'Zee', 'year': '1996', 'journal-title': 'Circulation'} / Circulation / A neutralizing antibody to the alpha v beta 3 integrin reduces neointimal thickening in a balloon-injured iliac artery by Zee (1996)
10.1126/science.7512751 / Science / Requirement of vascular integrin αvβ3 for angiogenesis by Brooks (1994)
10.1002/ijc.10265 / Int J Cancer / Alpha v-integrin antagonist EMD 121974 induces apoptosis in brain tumor cells growing on vitronectin and tenascin by Taga (2002)
10.1172/JCI118227 / J Clin Invest / Anti-integrin αvβ3 blocks human breast cancer growth and angiogenesis in human skin by Brooks (1995)
10.1006/jsre.1996.0242 / J Surg Res / β3 integrin expression in melanoma predicts subsequent metastasis by Hieken (1996)
{'key': '10.1016/S1367-5931(02)00350-2_BIB43', 'first-page': '6757', 'article-title': 'Integrin distribution in malignant melanoma: association of the β3 subunit with tumor progression', 'volume': '50', 'author': 'Albelda', 'year': '1990', 'journal-title': 'Cancer Res'} / Cancer Res / Integrin distribution in malignant melanoma: association of the β3 subunit with tumor progression by Albelda (1990)
10.1007/BF00690295 / Cancer Metastasis Rev / The role of the integrin vitronectin receptor αvβ3 in melanoma metastasis by Nip (1995)
10.1172/JCI0215468 / J Clin Invest / Integrins in invasive growth by Brakebusch (2002)
{'key': '10.1016/S1367-5931(02)00350-2_BIB46', 'first-page': '975', 'article-title': 'Expression and function of endothelial cell alpha v integrin receptors in wound-induced human angiogenesis in human skin/SCID mice chimeras', 'volume': '151', 'author': 'Christofidou-Solomidou', 'year': '1997', 'journal-title': 'Am J Pathol'} / Am J Pathol / Expression and function of endothelial cell alpha v integrin receptors in wound-induced human angiogenesis in human skin/SCID mice chimeras by Christofidou-Solomidou (1997)
{'key': '10.1016/S1367-5931(02)00350-2_BIB47', 'first-page': '1255', 'article-title': 'Integrin αvβ3 requirement for sustained mitogen-activated protein kinase activated protein kinase activity during angiogenesis', 'volume': '14', 'author': 'Eliceiri', 'year': '1999', 'journal-title': 'J Cell Biol'} / J Cell Biol / Integrin αvβ3 requirement for sustained mitogen-activated protein kinase activated protein kinase activity during angiogenesis by Eliceiri (1999)
10.1126/science.270.5241.1500 / Science / Definition of two angiogenic pathways by distinct αv integrins by Friedlander (1995)
10.1172/JCI6869 / J Clin Invest / The role of alpha v integrins during angiogenesis: insights into potential mechanisms of action and clinical development by Eliceiri (1999)
{'key': '10.1016/S1367-5931(02)00350-2_BIB50', 'first-page': '563', 'article-title': 'Antagonists of integrin αvβ3 inhibit retinal neovascularization in a murine model', 'volume': '75', 'author': 'Luna', 'year': '1996', 'journal-title': 'Lab Invest'} / Lab Invest / Antagonists of integrin αvβ3 inhibit retinal neovascularization in a murine model by Luna (1996)
10.1083/jcb.109.4.1817 / J Cell Biol / The osteoclast functional antigen, implicated in regulation of bone resorption, is biochemically related to the vitronectin receptor by Davies (1989)
10.1016/0014-4827(91)90386-9 / Exp Cell Res / Arg-Gly-Asp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts by Horton (1991)
10.1021/jm970205r / J Med Chem / Discovery of potent non-peptide vitronectin (αvβ3 integrin) antagonists by Keenan (1997)
10.1016/S0960-894X(97)00200-X / Bioorg Med Chem Lett / Solid phase synthesis of a selective αvβ3 integrin antagonist library by Corbett (1997)
Knolle J, Breiphol G, Guba W, Peman A, Scheunemann KH, Stilz VW, Baron R et al.: Design and synthesis of potent and selective peptidomimetic vitronectin receptor antagonists. In Peptide Chem Structure and Biol, Proceedings of the 15th AmPeptide Symp. Edited by Tam JP, Kaumaya TP. Kingswinford, England: Mayflower Books Ltd; 1997: Abst L 102.
{'key': '10.1016/S1367-5931(02)00350-2_BIB56', 'first-page': '959', 'article-title': 'Novel small molecule αv integrin antagonists: comparative anti-cancer efficacy with known angiogenesis inhibitors', 'volume': '19', 'author': 'Kerr', 'year': '1999', 'journal-title': 'Anticancer Res'} / Anticancer Res / Novel small molecule αv integrin antagonists: comparative anti-cancer efficacy with known angiogenesis inhibitors by Kerr (1999)
10.1097/00005344-199904000-00018 / J Cardiovasc Pharmacol / αvβ3 integrin binding affinity and specificity of SM256 in various species by Mousa (1999)
10.1126/science.279.5349.377 / Science / Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model by Arap (1998)
10.1038/nm0598-623 / Nat Med / Detection of tumor angiogenesis in vivo by avb3-targeted magnetic resonance imaging by Sipkins (1998)
10.1007/s002590050312 / Eur J Nucl Med / Imaging of metastatic melanoma utilizing a technetium-99m labeled RGD-containing synthetic peptide by Sivolapenko (1998)
{'key': '10.1016/S1367-5931(02)00350-2_BIB61', 'first-page': '1061', 'article-title': 'Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracer for tumor targeting', 'volume': '40', 'author': 'Haubner', 'year': '1999', 'journal-title': 'J Nucl Med'} / J Nucl Med / Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracer for tumor targeting by Haubner (1999)
10.1021/jm0102598 / J Med Chem / Nanomolar small molecule inhibitors for avb avb5, and avb3 integrins by Goodman (2002)

Dates

Type	When
Created	22 years, 11 months ago (Sept. 17, 2002, 12:34 p.m.)
Deposited	4 years, 3 months ago (May 27, 2021, 7:15 p.m.)
Indexed	1 month, 3 weeks ago (July 12, 2025, 6:50 p.m.)
Issued	23 years, 1 month ago (Aug. 1, 2002)
Published	23 years, 1 month ago (Aug. 1, 2002)
Published Print	23 years, 1 month ago (Aug. 1, 2002)

Funders 0

None

BibTeX

@article{Mousa_2002, title={Anti-integrin as novel drug-discovery targets: potential therapeutic and diagnostic implications}, volume={6}, ISSN={1367-5931}, url={http://dx.doi.org/10.1016/s1367-5931(02)00350-2}, DOI={10.1016/s1367-5931(02)00350-2}, number={4}, journal={Current Opinion in Chemical Biology}, publisher={Elsevier BV}, author={Mousa, Shaker A}, year={2002}, month=aug, pages={534–541} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        7,
        12
      ]
    ],
    "date-time": "2025-07-12T22:50:58Z",
    "timestamp": 1752360658108
  },
  "reference-count": 62,
  "publisher": "Elsevier BV",
  "issue": "4",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            2002,
            8,
            1
          ]
        ],
        "date-time": "2002-08-01T00:00:00Z",
        "timestamp": 1028160000000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "https://www.elsevier.com/tdm/userlicense/1.0/"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        2002,
        8
      ]
    ]
  },
  "DOI": "10.1016/s1367-5931(02)00350-2",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2002,
        9,
        17
      ]
    ],
    "date-time": "2002-09-17T16:34:42Z",
    "timestamp": 1032280482000
  },
  "page": "534-541",
  "source": "Crossref",
  "is-referenced-by-count": 49,
  "title": "Anti-integrin as novel drug-discovery targets: potential therapeutic and diagnostic implications",
  "prefix": "10.1016",
  "volume": "6",
  "author": [
    {
      "given": "Shaker A",
      "family": "Mousa",
      "sequence": "first",
      "affiliation": []
    }
  ],
  "member": "78",
  "reference": [
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB1",
      "doi-asserted-by": "crossref",
      "first-page": "517",
      "DOI": "10.1016/0092-8674(86)90259-X",
      "article-title": "Arg-Gly-Asp: a versatile cell recognition sequence",
      "volume": "44",
      "author": "Ruoslahti",
      "year": "1986",
      "journal-title": "Cell"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB2",
      "doi-asserted-by": "crossref",
      "first-page": "11",
      "DOI": "10.1016/0092-8674(92)90115-S",
      "article-title": "Integrins: versatility, modulation and signaling in cell adhesion",
      "volume": "69",
      "author": "Hynes",
      "year": "1992",
      "journal-title": "Cell"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB3",
      "doi-asserted-by": "crossref",
      "first-page": "195",
      "DOI": "10.1002/med.2610140203",
      "article-title": "The pharmacology of the integrins",
      "volume": "14",
      "author": "Cox",
      "year": "1994",
      "journal-title": "Med Res Rev"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB4",
      "doi-asserted-by": "crossref",
      "first-page": "2868",
      "DOI": "10.1096/fasebj.4.11.2199285",
      "article-title": "Integrins and other cell adhesion molecules",
      "volume": "4",
      "author": "Albelda",
      "year": "1990",
      "journal-title": "FASEB J"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB5",
      "doi-asserted-by": "crossref",
      "first-page": "225",
      "DOI": "10.1016/S1569-2558(08)60204-0",
      "article-title": "Integrins: structure, function and biological properties",
      "volume": "6",
      "author": "Cheresh",
      "year": "1993",
      "journal-title": "Adv Mol Cell Biol"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB6",
      "doi-asserted-by": "crossref",
      "first-page": "1572",
      "DOI": "10.1126/science.8248807",
      "article-title": "A link between cyclin A expression and adhesion dependent cell cycle proliferation",
      "volume": "262",
      "author": "Guadagno",
      "year": "1993",
      "journal-title": "Science"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB7",
      "doi-asserted-by": "crossref",
      "first-page": "577",
      "DOI": "10.1083/jcb.120.3.577",
      "article-title": "Signal transduction from the extracellular matrix",
      "volume": "120",
      "author": "Juliano",
      "year": "1993",
      "journal-title": "J Cell Biol"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB8",
      "doi-asserted-by": "crossref",
      "first-page": "8392",
      "DOI": "10.1073/pnas.88.19.8392",
      "article-title": "Signal transduction by integrins: increased protein tyrosine phosphorylation caused by clustering of \u03b21 integrins",
      "volume": "88",
      "author": "Kornberg",
      "year": "1991",
      "journal-title": "Proc Natl Acad Sci USA"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB9",
      "first-page": "1101",
      "article-title": "Cell adhesion or integrin clustering increased phosphorylation of a focal adhesion associated kinase",
      "volume": "117",
      "author": "Kornberg",
      "year": "1992",
      "journal-title": "J Biol Chem"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB10",
      "doi-asserted-by": "crossref",
      "first-page": "690",
      "DOI": "10.1038/358690a0",
      "article-title": "Regulation of focal adhesion-associated protein tyrosine kinase by both cellular adhesion and oncogenic transformation",
      "volume": "358",
      "author": "Guan",
      "year": "1992",
      "journal-title": "Nature"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB11",
      "doi-asserted-by": "crossref",
      "first-page": "989",
      "DOI": "10.1091/mbc.3.9.989",
      "article-title": "Signal transduction by the platelet integrin \u03b1IIb\u03b23: induction of calcium oscillations required for protein\u2013tyrosine phosphorylation and ligand-induced spreading of stably transfected cells",
      "volume": "3",
      "author": "Pelletier",
      "year": "1992",
      "journal-title": "Mol Biol Cell"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB12",
      "doi-asserted-by": "crossref",
      "first-page": "881",
      "DOI": "10.1016/S0140-6736(94)90007-8",
      "article-title": "Randomized trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months",
      "volume": "343",
      "author": "Topol",
      "year": "1994",
      "journal-title": "Lancet"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB13",
      "doi-asserted-by": "crossref",
      "first-page": "189",
      "DOI": "10.1016/S0140-6736(02)07442-1",
      "article-title": "Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials",
      "volume": "359",
      "author": "Boersma",
      "year": "2002",
      "journal-title": "Lancet"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB14",
      "doi-asserted-by": "crossref",
      "first-page": "552",
      "DOI": "10.1016/S1359-6446(99)01394-X",
      "article-title": "Antiplatelet therapies: from aspirin to GPIIb/IIIa receptor antagonists and beyond",
      "volume": "4",
      "author": "Mousa",
      "year": "1999",
      "journal-title": "Drug Discov Today"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB15",
      "doi-asserted-by": "crossref",
      "first-page": "747",
      "DOI": "10.1124/jpet.301.2.747",
      "article-title": "Pulmonary eosinophilia in a murine model of allergic inflammation is attenuated by small molecule alpha4beta1 antagonists",
      "volume": "301",
      "author": "Kudlacz",
      "year": "2002",
      "journal-title": "J Pharmacol Exp Ther"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB16",
      "doi-asserted-by": "crossref",
      "first-page": "185",
      "DOI": "10.1016/0092-8674(93)90305-A",
      "article-title": "\u03b14\u03b27 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1",
      "volume": "74",
      "author": "Berlin",
      "year": "1994",
      "journal-title": "Cell"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB17",
      "doi-asserted-by": "crossref",
      "first-page": "577",
      "DOI": "10.1016/0092-8674(90)90661-W",
      "article-title": "VCAM-1 on activated endothelium interacts with leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site",
      "volume": "60",
      "author": "Elices",
      "year": "1990",
      "journal-title": "Cell"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB18",
      "doi-asserted-by": "crossref",
      "first-page": "453",
      "DOI": "10.1016/S1367-5931(98)80120-8",
      "article-title": "Very late antigen 4 (VLA4) antagonists as anti-inflammatory agents",
      "volume": "2",
      "author": "Lin",
      "year": "1998",
      "journal-title": "Curr Opin Chem Biol"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB19",
      "doi-asserted-by": "crossref",
      "first-page": "391",
      "DOI": "10.1001/archneur.59.3.391",
      "article-title": "Migration of multiple sclerosis lymphocytes through brain endothelium",
      "volume": "59",
      "author": "Prat",
      "year": "2002",
      "journal-title": "Arch Neurol"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB20",
      "doi-asserted-by": "crossref",
      "first-page": "424",
      "DOI": "10.1002/ana.410370404",
      "article-title": "The adhesion molecule and cytokine profile of multiple sclerosis lesions",
      "volume": "37",
      "author": "Cannella",
      "year": "1995",
      "journal-title": "Ann Neurol"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB21",
      "doi-asserted-by": "crossref",
      "first-page": "301",
      "DOI": "10.1016/0092-8674(94)90337-9",
      "article-title": "Traffic signals for lymphocyte re-circulation and leukocyte emigration. The multistep paradigm",
      "volume": "76",
      "author": "Springer",
      "year": "1994",
      "journal-title": "Cell"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB22",
      "doi-asserted-by": "crossref",
      "first-page": "1363",
      "DOI": "10.1161/01.ATV.18.9.1363",
      "article-title": "Fibronectin: structure, assembly, and cardiovascular implications",
      "volume": "18",
      "author": "Magnusson",
      "year": "1998",
      "journal-title": "Arterioscler Thromb Vasc Biol"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB23",
      "doi-asserted-by": "crossref",
      "first-page": "269",
      "DOI": "10.1111/1523-1747.ep12500076",
      "article-title": "Blood vessel fibronectin increases in conjunction with endothelial cell proliferation and capillary ingrowth during wound healing",
      "volume": "79",
      "author": "Clark",
      "year": "1982",
      "journal-title": "J Invest Dermatol"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB24",
      "doi-asserted-by": "crossref",
      "first-page": "1271",
      "DOI": "10.1038/nbt1197-1271",
      "article-title": "Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform",
      "volume": "15",
      "author": "Neri",
      "year": "1997",
      "journal-title": "Nat Biotechnol"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB25",
      "doi-asserted-by": "crossref",
      "first-page": "1079",
      "DOI": "10.1242/dev.119.4.1079",
      "article-title": "Defects in mesodermal migration and vascular development in fibronectin-deficient mice",
      "volume": "119",
      "author": "George",
      "year": "1993",
      "journal-title": "Development"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB26",
      "doi-asserted-by": "crossref",
      "first-page": "11",
      "DOI": "10.1016/0092-8674(92)90115-S",
      "article-title": "Integrins: versatility, modulation and signaling in cell adhesion",
      "volume": "69",
      "author": "Hynes",
      "year": "1992",
      "journal-title": "Cell"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB27",
      "unstructured": "Varner J, Mousa S: Antagonists of vascular cell integrin \u03b15\u03b21 inhibit angiogenesis. Circulation 1998, 98(Suppl):1, I-795, 4166."
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB28",
      "unstructured": "Mousa S, Mohamed S, Smallhear J, Jadhav PK, Varner J: Anti-angiogenesis efficacy of small molecule a5b1 integrin antagonist, SJ749. Blood 1999, 94(Suppl I):620a, 2755."
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB29",
      "doi-asserted-by": "crossref",
      "first-page": "2858",
      "DOI": "10.1073/pnas.050587897",
      "article-title": "A non-peptide integrin antagonist can inhibit epithelial cell ingestion of streptococcus by blocking a5b1-fibronectin-M1 protein complex",
      "volume": "97",
      "author": "Cleary",
      "year": "2000",
      "journal-title": "Proc Natl Acad Sci USA"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB30",
      "doi-asserted-by": "crossref",
      "first-page": "S113",
      "DOI": "10.1016/S0002-8703(98)70239-X",
      "article-title": "Long-term administration of glycoprotein IIb/IIIa antagonists",
      "volume": "135",
      "author": "Quinn",
      "year": "1998",
      "journal-title": "Am Heart J"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB31",
      "doi-asserted-by": "crossref",
      "first-page": "340",
      "DOI": "10.1161/01.CIR.97.4.340",
      "article-title": "Randomized trial of an oral platelet glycoprotein IIb/IIIa antagonist, sibrafiban, in patients after an acute coronary syndrome: results of the TIMI 12 trial. Thrombolysis in myocardial infarction",
      "volume": "97",
      "author": "Cannon",
      "year": "1998",
      "journal-title": "Circulation"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB32",
      "doi-asserted-by": "crossref",
      "first-page": "1268",
      "DOI": "10.1161/01.CIR.98.13.1268",
      "article-title": "Pharmacodynamic efficacy, clinical safety, and outcomes after prolonged platelet glycoprotein IIb/IIIa receptor blockade with oral xemilofiban: results of a multicenter, placebo-controlled, randomized trial",
      "volume": "98",
      "author": "Kereiakes",
      "year": "1998",
      "journal-title": "Circulation"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB33",
      "first-page": "393A",
      "article-title": "Thrombocytopenia, bleeding, and thrombotic events with oral glycoprotein IIb/IIIa inhibition: results from OPUS-TIMI 16",
      "volume": "35",
      "author": "Coulter",
      "year": "2000",
      "journal-title": "J Am Coll Cardiol Suppl"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB34",
      "doi-asserted-by": "crossref",
      "unstructured": "The SYMPHONY Investigators: Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomized trial. Lancet 2000, 355:337-345. First published report of a large Phase III trial with an oral IIb/IIIa inhibitor.",
      "DOI": "10.1016/S0140-6736(99)11179-6"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB35",
      "doi-asserted-by": "crossref",
      "first-page": "S332",
      "DOI": "10.1097/00003246-200205001-00025",
      "article-title": "Platelet glycoprotein Iib/IIIa antagonists: lessons learned from clinical trials and future directions",
      "volume": "30",
      "author": "Leclerc",
      "year": "2002",
      "journal-title": "Crit Care Med"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB36",
      "doi-asserted-by": "crossref",
      "first-page": "131",
      "DOI": "10.1097/00019501-199809020-00011",
      "article-title": "Novel technetium 99m-labeled GPIIb/IIIa receptor antagonists as potential imaging agents for venous and arterial thrombosis",
      "volume": "9",
      "author": "Mousa",
      "year": "1998",
      "journal-title": "Coron Artery Dis"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB37",
      "doi-asserted-by": "crossref",
      "first-page": "408",
      "DOI": "10.1016/S0008-6363(97)00184-3",
      "article-title": "Selective \u03b1v\u03b23 integrin blockade limits neointima hyperplasia and lumen stenosis in stented porcine coronary artery injury in pig",
      "volume": "36",
      "author": "Srivatsa",
      "year": "1997",
      "journal-title": "Cardiovasc Res"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB38",
      "first-page": "1505",
      "article-title": "A neutralizing antibody to the alpha v beta 3 integrin reduces neointimal thickening in a balloon-injured iliac artery",
      "volume": "94",
      "author": "Zee",
      "year": "1996",
      "journal-title": "Circulation"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB39",
      "doi-asserted-by": "crossref",
      "first-page": "569",
      "DOI": "10.1126/science.7512751",
      "article-title": "Requirement of vascular integrin \u03b1v\u03b23 for angiogenesis",
      "volume": "264",
      "author": "Brooks",
      "year": "1994",
      "journal-title": "Science"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB40",
      "doi-asserted-by": "crossref",
      "first-page": "690",
      "DOI": "10.1002/ijc.10265",
      "article-title": "Alpha v-integrin antagonist EMD 121974 induces apoptosis in brain tumor cells growing on vitronectin and tenascin",
      "volume": "98",
      "author": "Taga",
      "year": "2002",
      "journal-title": "Int J Cancer"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB41",
      "doi-asserted-by": "crossref",
      "first-page": "1815",
      "DOI": "10.1172/JCI118227",
      "article-title": "Anti-integrin \u03b1v\u03b23 blocks human breast cancer growth and angiogenesis in human skin",
      "volume": "96",
      "author": "Brooks",
      "year": "1995",
      "journal-title": "J Clin Invest"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB42",
      "doi-asserted-by": "crossref",
      "first-page": "169",
      "DOI": "10.1006/jsre.1996.0242",
      "article-title": "\u03b23 integrin expression in melanoma predicts subsequent metastasis",
      "volume": "63",
      "author": "Hieken",
      "year": "1996",
      "journal-title": "J Surg Res"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB43",
      "first-page": "6757",
      "article-title": "Integrin distribution in malignant melanoma: association of the \u03b23 subunit with tumor progression",
      "volume": "50",
      "author": "Albelda",
      "year": "1990",
      "journal-title": "Cancer Res"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB44",
      "doi-asserted-by": "crossref",
      "first-page": "241",
      "DOI": "10.1007/BF00690295",
      "article-title": "The role of the integrin vitronectin receptor \u03b1v\u03b23 in melanoma metastasis",
      "volume": "14",
      "author": "Nip",
      "year": "1995",
      "journal-title": "Cancer Metastasis Rev"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB45",
      "doi-asserted-by": "crossref",
      "first-page": "999",
      "DOI": "10.1172/JCI0215468",
      "article-title": "Integrins in invasive growth",
      "volume": "109",
      "author": "Brakebusch",
      "year": "2002",
      "journal-title": "J Clin Invest"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB46",
      "first-page": "975",
      "article-title": "Expression and function of endothelial cell alpha v integrin receptors in wound-induced human angiogenesis in human skin/SCID mice chimeras",
      "volume": "151",
      "author": "Christofidou-Solomidou",
      "year": "1997",
      "journal-title": "Am J Pathol"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB47",
      "first-page": "1255",
      "article-title": "Integrin \u03b1v\u03b23 requirement for sustained mitogen-activated protein kinase activated protein kinase activity during angiogenesis",
      "volume": "14",
      "author": "Eliceiri",
      "year": "1999",
      "journal-title": "J Cell Biol"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB48",
      "doi-asserted-by": "crossref",
      "first-page": "1500",
      "DOI": "10.1126/science.270.5241.1500",
      "article-title": "Definition of two angiogenic pathways by distinct \u03b1v integrins",
      "volume": "27",
      "author": "Friedlander",
      "year": "1995",
      "journal-title": "Science"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB49",
      "doi-asserted-by": "crossref",
      "first-page": "1227",
      "DOI": "10.1172/JCI6869",
      "article-title": "The role of alpha v integrins during angiogenesis: insights into potential mechanisms of action and clinical development",
      "volume": "103",
      "author": "Eliceiri",
      "year": "1999",
      "journal-title": "J Clin Invest"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB50",
      "first-page": "563",
      "article-title": "Antagonists of integrin \u03b1v\u03b23 inhibit retinal neovascularization in a murine model",
      "volume": "75",
      "author": "Luna",
      "year": "1996",
      "journal-title": "Lab Invest"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB51",
      "doi-asserted-by": "crossref",
      "first-page": "1817",
      "DOI": "10.1083/jcb.109.4.1817",
      "article-title": "The osteoclast functional antigen, implicated in regulation of bone resorption, is biochemically related to the vitronectin receptor",
      "volume": "109",
      "author": "Davies",
      "year": "1989",
      "journal-title": "J Cell Biol"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB52",
      "doi-asserted-by": "crossref",
      "first-page": "368",
      "DOI": "10.1016/0014-4827(91)90386-9",
      "article-title": "Arg-Gly-Asp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts",
      "volume": "195",
      "author": "Horton",
      "year": "1991",
      "journal-title": "Exp Cell Res"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB53",
      "doi-asserted-by": "crossref",
      "first-page": "2289",
      "DOI": "10.1021/jm970205r",
      "article-title": "Discovery of potent non-peptide vitronectin (\u03b1v\u03b23 integrin) antagonists",
      "volume": "40",
      "author": "Keenan",
      "year": "1997",
      "journal-title": "J Med Chem"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB54",
      "doi-asserted-by": "crossref",
      "first-page": "1371",
      "DOI": "10.1016/S0960-894X(97)00200-X",
      "article-title": "Solid phase synthesis of a selective \u03b1v\u03b23 integrin antagonist library",
      "volume": "7",
      "author": "Corbett",
      "year": "1997",
      "journal-title": "Bioorg Med Chem Lett"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB55",
      "unstructured": "Knolle J, Breiphol G, Guba W, Peman A, Scheunemann KH, Stilz VW, Baron R et al.: Design and synthesis of potent and selective peptidomimetic vitronectin receptor antagonists. In Peptide Chem Structure and Biol, Proceedings of the 15th AmPeptide Symp. Edited by Tam JP, Kaumaya TP. Kingswinford, England: Mayflower Books Ltd; 1997: Abst L 102."
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB56",
      "first-page": "959",
      "article-title": "Novel small molecule \u03b1v integrin antagonists: comparative anti-cancer efficacy with known angiogenesis inhibitors",
      "volume": "19",
      "author": "Kerr",
      "year": "1999",
      "journal-title": "Anticancer Res"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB57",
      "doi-asserted-by": "crossref",
      "first-page": "641",
      "DOI": "10.1097/00005344-199904000-00018",
      "article-title": "\u03b1v\u03b23 integrin binding affinity and specificity of SM256 in various species",
      "volume": "33",
      "author": "Mousa",
      "year": "1999",
      "journal-title": "J Cardiovasc Pharmacol"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB58",
      "doi-asserted-by": "crossref",
      "first-page": "377",
      "DOI": "10.1126/science.279.5349.377",
      "article-title": "Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model",
      "volume": "279",
      "author": "Arap",
      "year": "1998",
      "journal-title": "Science"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB59",
      "doi-asserted-by": "crossref",
      "first-page": "623",
      "DOI": "10.1038/nm0598-623",
      "article-title": "Detection of tumor angiogenesis in vivo by avb3-targeted magnetic resonance imaging",
      "volume": "4",
      "author": "Sipkins",
      "year": "1998",
      "journal-title": "Nat Med"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB60",
      "doi-asserted-by": "crossref",
      "first-page": "1383",
      "DOI": "10.1007/s002590050312",
      "article-title": "Imaging of metastatic melanoma utilizing a technetium-99m labeled RGD-containing synthetic peptide",
      "volume": "25",
      "author": "Sivolapenko",
      "year": "1998",
      "journal-title": "Eur J Nucl Med"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB61",
      "first-page": "1061",
      "article-title": "Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracer for tumor targeting",
      "volume": "40",
      "author": "Haubner",
      "year": "1999",
      "journal-title": "J Nucl Med"
    },
    {
      "key": "10.1016/S1367-5931(02)00350-2_BIB62",
      "doi-asserted-by": "crossref",
      "first-page": "1045",
      "DOI": "10.1021/jm0102598",
      "article-title": "Nanomolar small molecule inhibitors for avb avb5, and avb3 integrins",
      "volume": "45",
      "author": "Goodman",
      "year": "2002",
      "journal-title": "J Med Chem"
    }
  ],
  "container-title": "Current Opinion in Chemical Biology",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://api.elsevier.com/content/article/PII:S1367593102003502?httpAccept=text/xml",
      "content-type": "text/xml",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.elsevier.com/content/article/PII:S1367593102003502?httpAccept=text/plain",
      "content-type": "text/plain",
      "content-version": "vor",
      "intended-application": "text-mining"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2021,
        5,
        27
      ]
    ],
    "date-time": "2021-05-27T23:15:08Z",
    "timestamp": 1622157308000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://linkinghub.elsevier.com/retrieve/pii/S1367593102003502"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2002,
        8
      ]
    ]
  },
  "references-count": 62,
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          2002,
          8
        ]
      ]
    }
  },
  "alternative-id": [
    "S1367593102003502"
  ],
  "URL": "http://dx.doi.org/10.1016/S1367-5931(02)00350-2",
  "relation": {},
  "ISSN": [
    "1367-5931"
  ],
  "subject": [],
  "container-title-short": "Current Opinion in Chemical Biology",
  "published": {
    "date-parts": [
      [
        2002,
        8
      ]
    ]
  }
}